NIB Holdings Ltd (ASX: NHF) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
NIB Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
NIB Holdings Ltd (ASX: NHF)
Latest News
Dividend Investing
Cash in the hand: 3 ASX dividend shares to know about
Share Fallers
Why Catalyst Metals, Lotus Resources, NIB, and Woodside shares are dropping today
ASX Share Market News
5 things to watch on the ASX 200 on Thursday
Healthcare Shares
ASX health insurance shares: Does Macquarie still prefer NIB over Medibank Private shares?
Broker Notes
Macquarie predicts 25% downside for this blue chip ASX 200 stock
Earnings Results
Guess which ASX 200 stock is racing to 52-week high on solid FY25 results
52-Week Highs
12 ASX 200 shares that smashed multi-year highs today
Financial Shares
Up 33% this year, does Macquarie rate Medibank Private shares a buy, hold or sell?
Healthcare Shares
What's Macquarie's price target for NIB shares?
Share Fallers
Why CBA, HMC Capital, Mineral Resources, and NIB shares are falling today
Healthcare Shares
Macquarie expects this ASX All Ords healthcare stock to fall 21% in FY26
Share Gainers
Here are the top 10 ASX 200 shares today
Frequently Asked Questions
-
The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.
In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.
-
NIB pays a fully franked dividend in April and October.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 03 Sep 2026 | $0.0500 | 100.00% | Special Cash | 07 Oct 2026 |
| 03 Sep 2026 | $0.1600 | 100.00% | Final | 07 Oct 2026 |
| 05 Mar 2026 | $0.1300 | 100.00% | Interim | 08 Apr 2026 |
| 04 Sep 2025 | $0.1600 | 100.00% | Final | 07 Oct 2025 |
| 06 Mar 2025 | $0.1300 | 100.00% | Interim | 09 Apr 2025 |
| 05 Sep 2024 | $0.1400 | 100.00% | Final | 08 Oct 2024 |
| 07 Mar 2024 | $0.1500 | 100.00% | Interim | 10 Apr 2024 |
| 04 Sep 2023 | $0.1500 | 100.00% | Final | 03 Oct 2023 |
| 02 Mar 2023 | $0.1300 | 100.00% | Interim | 03 Apr 2023 |
| 05 Sep 2022 | $0.1100 | 100.00% | Final | 04 Oct 2022 |
| 03 Mar 2022 | $0.1100 | 100.00% | Interim | 04 Apr 2022 |
| 02 Sep 2021 | $0.1400 | 100.00% | Final | 05 Oct 2021 |
| 04 Mar 2021 | $0.1000 | 100.00% | Interim | 06 Apr 2021 |
| 03 Sep 2020 | $0.0400 | 100.00% | Final | 06 Oct 2020 |
| 05 Mar 2020 | $0.1000 | 100.00% | Interim | 07 Apr 2020 |
| 02 Sep 2019 | $0.1300 | 100.00% | Final | 30 Sep 2019 |
| 06 Sep 2018 | $0.1100 | 100.00% | Final | 05 Oct 2018 |
| 01 Mar 2018 | $0.0900 | 100.00% | Interim | 03 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 02 Mar 2017 | $0.0850 | 100.00% | Interim | 03 Apr 2017 |
| 08 Sep 2016 | $0.0900 | 100.00% | Final | 07 Oct 2016 |
| 02 Mar 2016 | $0.0575 | 100.00% | Interim | 01 Apr 2016 |
| 10 Sep 2014 | $0.0900 | 100.00% | Special Cash | 03 Oct 2014 |
| 10 Sep 2014 | $0.0575 | 100.00% | Final | 03 Oct 2014 |
| 05 Sep 2013 | $0.0500 | 100.00% | Final | 04 Oct 2013 |
| 04 Mar 2013 | $0.0500 | 100.00% | Interim | 05 Apr 2013 |
| 05 Mar 2012 | $0.0425 | 100.00% | Interim | 05 Apr 2012 |
| 07 Mar 2011 | $0.0400 | 100.00% | Interim | 08 Apr 2011 |
| 05 Mar 2010 | $0.0200 | 100.00% | Interim | 08 Apr 2010 |
| 14 Sep 2009 | $0.0440 | 100.00% | Final | 09 Oct 2009 |
NHF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About NIB Holdings Ltd
NIB Holdings Limited (ASX: NHF) provides health and medical insurance to nearly 2 million Australian and New Zealand residents. In addition, it covers international students and workers in Australia.
The company also offers travel insurance through its NIB Travel business, and provides health insurance plans to corporate groups through its GU Health business.
NHF Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 17 Sep 2026 | $6.55 | $-0.02 | -0.30% | 1,463,403 | $6.65 | $6.65 | $6.55 |
| 16 Sep 2026 | $6.57 | $-0.09 | -1.35% | 659,763 | $6.61 | $6.70 | $6.56 |
| 15 Sep 2026 | $6.66 | $0.11 | 1.68% | 817,427 | $6.62 | $6.67 | $6.55 |
| 14 Sep 2026 | $6.55 | $0.02 | 0.31% | 760,691 | $6.49 | $6.59 | $6.49 |
| 11 Sep 2026 | $6.53 | $0.08 | 1.24% | 509,014 | $6.44 | $6.56 | $6.44 |
| 10 Sep 2026 | $6.45 | $-0.03 | -0.46% | 606,273 | $6.42 | $6.50 | $6.42 |
| 09 Sep 2026 | $6.48 | $-0.07 | -1.07% | 600,643 | $6.50 | $6.53 | $6.46 |
| 08 Sep 2026 | $6.55 | $-0.08 | -1.21% | 484,556 | $6.70 | $6.70 | $6.55 |
| 07 Sep 2026 | $6.63 | $-0.05 | -0.75% | 412,677 | $6.68 | $6.68 | $6.61 |
| 04 Sep 2026 | $6.68 | $-0.04 | -0.60% | 729,375 | $6.67 | $6.72 | $6.62 |
| 03 Sep 2026 | $6.72 | $-0.25 | -3.59% | 791,092 | $6.86 | $6.87 | $6.69 |
| 02 Sep 2026 | $6.97 | $0.07 | 1.01% | 2,125,971 | $6.86 | $7.01 | $6.84 |
| 01 Sep 2026 | $6.90 | $0.10 | 1.47% | 1,155,439 | $6.79 | $6.90 | $6.74 |
| 31 Aug 2026 | $6.80 | $0.06 | 0.89% | 1,004,190 | $6.88 | $6.88 | $6.74 |
| 28 Aug 2026 | $6.74 | $0.02 | 0.30% | 556,633 | $6.70 | $6.76 | $6.66 |
| 27 Aug 2026 | $6.72 | $-0.13 | -1.90% | 968,643 | $6.84 | $6.87 | $6.70 |
| 26 Aug 2026 | $6.85 | $0.03 | 0.44% | 1,231,149 | $6.85 | $6.93 | $6.75 |
| 25 Aug 2026 | $6.82 | $0.09 | 1.34% | 3,579,515 | $6.77 | $6.85 | $6.67 |
| 24 Aug 2026 | $6.73 | $-0.67 | -9.05% | 5,234,510 | $7.01 | $7.25 | $6.56 |
| 21 Aug 2026 | $7.40 | $0.31 | 4.37% | 705,663 | $7.09 | $7.40 | $7.06 |
| 20 Aug 2026 | $7.09 | $-0.40 | -5.34% | 1,247,032 | $7.30 | $7.34 | $7.02 |
| 19 Aug 2026 | $7.49 | $0.09 | 1.22% | 551,829 | $7.40 | $7.50 | $7.37 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Sep 2026 | Edward Close | Expiry | 32,814 | $226,416 |
As advised by the company. performance rights lapsed, 385,555 rights
|
| 01 Sep 2026 | Edward Close | Buy | 13,605 | $93,874 |
Conversion of securities.
|
| 01 Sep 2026 | Edward Close | Buy | 68,210 | $470,649 |
On-market trade.
|
| 01 Sep 2026 | Edward Close | Exercise | 13,605 | $93,874 |
Conversion of securities. 418,369 rights
|
| 28 Aug 2026 | David Gordon | Buy | 5,000 | $33,649 |
On-market trade.
|
| 28 Aug 2026 | Jill Watts | Buy | 388 | $2,599 |
On-market trade.
|
| 27 Aug 2026 | Jill Watts | Buy | 4,123 | $27,624 |
On-market trade.
|
| 25 Aug 2026 | Brad Welsh | Buy | 6,686 | $44,996 |
On-market trade.
|
| 14 May 2026 | David Gordon | Buy | 5,000 | $32,815 |
On-market trade.
|
| 21 Jan 2026 | Edward Close | Issued | 178,768 | $1,188,807 |
Issue of securities. 431,974 Rights
|
| 24 Sep 2025 | Edward Close | Transfer | 38,052 | $283,867 |
Off-market transfer.
|
| 24 Sep 2025 | Edward Close | Transfer | 38,052 | $283,867 |
Off-market transfer.
|
| 23 Sep 2025 | Edward Close | Sell | 17,021 | $125,932 |
On-market trade.
|
| 23 Sep 2025 | Edward Close | Sell | 36,715 | $271,975 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David L Gordon | Non-Executive DirectorNon-Executive Chairman | May 2020 |
Mr Gordon has over 30 years of experience as a Director of both public and private companies and in corporate advisory roles to Australian and international organizations. He brings knowledge of strategy development, mergers and acquisitions, as well as capital raisings, IPOs and joint ventures. David was formerly a Partner with Freehills (now Herbert Smith Freehills Kramer) and boutique investment bank Wentworth Associates. David is Chair of Kinyara Health Pty Ltd, Genesis Capital Manager I Pty Ltd and Genesis Capital Manager II Pty Ltd (the management entities of the Genesis Capital Fund I and Genesis Capital Fund II healthcare investment funds, respectively).
|
| Ms Anne Joan Loveridge | Non-Executive Director | Feb 2017 |
Ms Loveridge has more than 35 years of experience in the financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. Anne has experience in financial reporting, auditing, risk, ethics and regulatory affairs. She spent more than 30 years with PwC in the UK and Australia, where she was a Senior Audit Partner and Deputy Chair of the Australian Firm until 2015. In 2023, Anne was made a Member of the Order of Australia.
|
| Mr Peter Harmer | Non-Executive Director | Jul 2021 |
Mr Harmer has over 45 years experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. Peter was formerly Chief Executive Officer of Insurance Australia Group (IAG), CGU Insurance, Aon Limited UK, Aon Risk Services Australia Pacific and Aon Re Australia. Prior to his role as Chief Executive Officer at IAG, he took up a secondment role as Chief Digital Officer. Peter is currently a Non-Executive Director of Commonwealth Bank of Australia, and Chair of AUB Group Limited. Peter is the Chair of Lawcover Insurance Pty Ltd. He is the Chair of the Risk and Reputation Committee, and a member of the People Committee.
|
| Ms Jacqueline Chow | Non-Executive Director | Apr 2018 |
Ms Chow has more than 20 years experience in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. She was previously Deputy Chair of Global Dairy Platform and a Director of Fisher & Paykel Appliances in New Zealand, Dairy Partners Americas, the Riddet Institute (Massey University NZ) and The Arnotts Foundation. Jacqueline is a senior advisor with McKinsey & Companys Transformation Practice where she advises clients across resources, retail, financial services, telecommunications and consumer sectors on organisational change and performance culture. Jacqueline is currently a Non-Executive Director of Coles Group Limited, Charter Hall Group and Reece Limited. She is Chair of the People Committee.
|
| Mr Brad Welsh | Non-Executive Director | Jul 2023 |
Mr Welsh advising global resource companies, including Energy Resources of Australia and Rio Tinto, bringing both public sector and commercial skills to his role on nibs Board. Brad brings to the nib Board commercial. Brad is the Chief Executive Officer and Managing Director at Energy Resources of Australia Limited.He is a member of the Risk and Reputation Committee, People Committee.
|
| Ms Jill Watts | Non-Executive Director | Jul 2023 |
Ms Watts has more than 40 years experience in global businesses. She has worked across the private sector, with governments affecting public policy change, and private research institutes. She has experience working with companies with operations in Australia, the UK, France, and South Africa. Prior to returning to Australia in 2017, Jill was the Group CEO of the UKs private hospital group, BMI Healthcare, responsible for 60 facilities across the UK. Jill was also Group CEO of Ramsay Healthcare, UK. In 2010. She has joined the Boards of a range of global companies since returning to Australia. Jill is a prior Director of the Australian Chamber of Commerce, UK, The Royal Australian Flying Doctor Service, UK, Netcare Hospital Group, South Africa, Ramsay Generale de Sante France, and Chair of Healthcare Logic Global Group. She was a Board member at Keyton, a retirement villages business, formerly known as Lendlease Retirement Living. Jill is currently a Non-Executive Director at St Vincent Healthcare and Icon Cancer Group. She is the Chair of the Clinical Governance Committee, and a member Risk and Reputation Committee.
|
| Mr Edward Close | Chief Executive OfficerManaging Director | Dec 2024 |
Mr Close brings experience in financial services and health insurance, having overseen P&L, distribution, customer, digital and marketing functions. Ed has previously held senior management roles at the Commonwealth Bank of Australia, where he worked across product management, strategy and customer engagement in the consumer banking division. He was a member of, Private Healthcare Australia, Risk Committee.
|
| Mr Hisham El-Ansary | Non-Executive Director | Dec 2025 |
Mr El-Ansary has more than 30 years of executive experience across healthcare, insurance, retail, aviation, and construction consulting in Australia, and the Asia-Pacific region. He has experience in health insurance with 15 years at BUPA, including serving as Chief Executive Officer for BUPA AsiaPacific from 2019 to 2023. Hisham is a Non-Executive Director of Royal Automobile Club of Victoria Limited (RACV). He is a member of the People and the Clinical Governance Committee.
|
| Mr Jordan French | Senior Corporate CounselJoint Company Secretary | Aug 2017 |
-
|
| Nick Freeman | CFO |
-
|
|
| Rachel Sandhu | Chief Risk Officer |
-
|
|
| Jordan French | General Counsel/Secretary |
-
|
|
| Lauren Daniels | Other Corporate Officer |
-
|
|
| Linda Da Silva | Other Corporate Officer |
-
|
|
| Matthew Neat | Other Corporate Officer |
-
|
|
| Rhod McKensey | Other Corporate Officer |
-
|
|
| Skye Daniels | Other Corporate Officer |
-
|
|
| Jordan French | Senior Corporate CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limitedi | 99,241,934 | 20.30% |
| Citicorp Nominees Pty Limited | 64,290,721 | 13.15% |
| J P Morgan Nominees Australia Pty Limited | 54,234,721 | 11.09% |
| BNP Paribas Noms Pty Ltdi | 15,031,024 | 3.07% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 4,422,412 | 0.90% |
| BNP Paribas Nominees Pty Ltdii | 1,863,014 | 0.38% |
| BNP Paribas Nominees Pty Ltdiii | 1,254,212 | 0.26% |
| Netwealth Investments Limited <Wrap Services A/C> | 1,012,147 | 0.21% |
| Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 812,354 | 0.17% |
| Ioof Investment Services Limited <Ips Superfund A/C> | 803,180 | 0.16% |
| Ubs Nominees Pty Ltd | 758,301 | 0.16% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 723,843 | 0.15% |
| Bnp Paribas Noms (Nz) Ltd | 615,846 | 0.13% |
| Netwealth Investments Limited <Super Services A/C> | 539,857 | 0.11% |
| Cpu Share Plans Pty Ltd <Nhf Escrow Trust Master A/C> | 483,873 | 0.10% |
| Ioof Investment Services Limited <Ioof Idps A/C> | 416,136 | 0.09% |
| HSBC Custody Nominees (Australia) Limitedii | 338,055 | 0.07% |
| Brencam Pty Limited | 316,371 | 0.06% |
| Mr Graham Robert Woods | 310,600 | 0.06% |
| Moorgate Investments Pty Ltd | 235,795 | 0.05% |